Unique ID issued by UMIN | UMIN000047538 |
---|---|
Receipt number | R000054212 |
Scientific Title | Randomized controlled trial of dialyzer used by dialysis initiation patients with discontinuation of production of EVAL membrane dialyzer |
Date of disclosure of the study information | 2022/05/01 |
Last modified on | 2022/04/20 16:27:06 |
Randomized controlled trial of dialyzer used by dialysis initiation patients with discontinuation of production of EVAL membrane dialyzer
Initiating dialyzer trial
Randomized controlled trial of dialyzer used by dialysis initiation patients with discontinuation of production of EVAL membrane dialyzer
Initiating dialyzer trial
Japan |
Chronic Renal Failure
Nephrology |
Others
NO
The production of the EVAL membrane dialyzer, which has been used as a initiating dialyzer in our hospital, has been discontinued, so we will compare dialyzer with different types of materials, and verify the optimal dialyzer while observing the remaining renal function and nutritional status.
Efficacy
Indefinite complaint and nutritional status 0, 2, 6, 12 months after dialysis initiation.
3 years survival rate after dialysis initiation.
Residual renal function 0, 2, 6, 12 months after dialysis initiation.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Institution is not considered as adjustment factor.
NO
No need to know
4
Treatment
Device,equipment |
Treatment with one dialyzer chosen from NF-U.
Treatment with one dialyzer chosen from.FDX
Treatment with one dialyzer chosen from .PES-Galpha.
Treatment with one dialyzer chosen from.VPS-HA.
Not applicable |
Not applicable |
Male and Female
Hemodialysis initiation patients
Patients >= 20 years and <85 years of age at the time of informed consent.
Medical history of the peritoneal dialysis.
Difficulties for self-management.
Patients who are going to be transferred to another hospital.
Patients in the opinion of the principal investigator to disqualify from participation.
60
1st name | Ikuto |
Middle name | |
Last name | Masakane |
Medical corporation Seieikai
Yabuki hospital
Renal failure measures room manager
9900980
5-5,shimaKita-4tyoume,Yamagata
023-682-8566
imasakan.aipod@seieig.or.jp
1st name | Norio |
Middle name | |
Last name | Suzuki |
Medical corporation Seieikai
Department of clinical engineering
9900043
6-17,honntyou1tyome,Yamagata
023-615-1877
suzukin@seieig.or.jp
Medical corporation Seieikai
Yabuki hospital
Medical corporation Seieikai
Yabuki hospital
Self funding
Medical corporation Seieikai
Honmachi Yabuki clinic
Tendou Onsen Yabuki clinic
Nanyou Yabuki clinic
Medical corporation Seieikai Yabuki hospitalEthics Review Board
5-5,shimaKita-4tyoume,Yamagata
023-682-8566
imasakan.aipod@seieig.or.jp
NO
2022 | Year | 05 | Month | 01 | Day |
Unpublished
60
No longer recruiting
2019 | Year | 05 | Month | 01 | Day |
2019 | Year | 05 | Month | 01 | Day |
2019 | Year | 11 | Month | 01 | Day |
2024 | Year | 09 | Month | 01 | Day |
Enrollment in this clinical study is planned that the initiation dialysis patients who meet our criteria for selection are sequentially chosen. Hemodialysis is performed using four dialyzers(NF-U,FDX,PES-Galfa,VPS-HA).The surface area of dialyzer is chosen size suitable for each research participants. Research participants are randomized by assigned to one of dialyzers sequentially.
2022 | Year | 04 | Month | 20 | Day |
2022 | Year | 04 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054212
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |